153 related articles for article (PubMed ID: 37376155)
21. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles.
Lippacher A; Müller RH; Mäder K
Int J Pharm; 2001 Feb; 214(1-2):9-12. PubMed ID: 11282228
[TBL] [Abstract][Full Text] [Related]
22. Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate.
Stigliani M; Manniello MD; Zegarra-Moran O; Galietta L; Minicucci L; Casciaro R; Garofalo E; Incarnato L; Aquino RP; Del Gaudio P; Russo P
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):337-45. PubMed ID: 26741302
[TBL] [Abstract][Full Text] [Related]
23. In vitro permeation profile of a local anaesthetic compound from topical formulations with different rheological behaviour--verified by in vivo efficacy data.
Welin-Berger K; Neelissen J; Bergenståhl B
Eur J Pharm Sci; 2001 Oct; 14(3):229-36. PubMed ID: 11576828
[TBL] [Abstract][Full Text] [Related]
24. [A study on release of propolis extract components from emulsion-type dispersions].
Ramanauskienė K; Zilius M; Briedis V
Medicina (Kaunas); 2011; 47(6):354-9. PubMed ID: 21968889
[TBL] [Abstract][Full Text] [Related]
25. The effect of rheological behaviour of a topical anaesthetic formulation on the release and permeation rates of the active compound.
Welin-Berger K; Neelissen JA; Bergenståhl B
Eur J Pharm Sci; 2001 Jun; 13(3):309-18. PubMed ID: 11384854
[TBL] [Abstract][Full Text] [Related]
26. Rheological characterization and permeation behavior of poloxamer 407-based systems containing 5-aminolevulinic acid for potential application in photodynamic therapy.
van Hemelrijck C; Müller-Goymann CC
Int J Pharm; 2012 Nov; 437(1-2):120-9. PubMed ID: 22898092
[TBL] [Abstract][Full Text] [Related]
27. The influence of volatile solvents on transport across model membranes and human skin.
Oliveira G; Hadgraft J; Lane ME
Int J Pharm; 2012 Oct; 435(1):38-49. PubMed ID: 22634140
[TBL] [Abstract][Full Text] [Related]
28. Reconstructed Human Epidermis: An Alternative Approach for In Vitro Bioequivalence Testing of Topical Products.
Agonia AS; Palmeira-de-Oliveira A; Cardoso C; Augusto C; Pellevoisin C; Videau C; Dinis-Oliveira RJ; Palmeira-de-Oliveira R
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893811
[TBL] [Abstract][Full Text] [Related]
29. Method to determine the impact of substantivity on ex vivo skin-permeation.
Schmidberger M; Daniels R; Lunter DJ
Eur J Pharm Biopharm; 2018 Oct; 131():1-7. PubMed ID: 30048744
[TBL] [Abstract][Full Text] [Related]
30. In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations.
Santos LL; Swofford NJ; Santiago BG
Curr Protoc Pharmacol; 2020 Dec; 91(1):e79. PubMed ID: 32991075
[TBL] [Abstract][Full Text] [Related]
31. Biopharmaceutical Study of Triamcinolone Acetonide Semisolid Formulations for Sublingual and Buccal Administration.
Márquez Valls M; Martínez Labrador A; Halbaut Bellowa L; Bravo Torres D; Granda PC; Miñarro Carmona M; Limón D; Calpena Campmany AC
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371771
[TBL] [Abstract][Full Text] [Related]
32. Rheological stability of carbomer in hydroalcoholic gels: Influence of alcohol type.
Kolman M; Smith C; Chakrabarty D; Amin S
Int J Cosmet Sci; 2021 Dec; 43(6):748-763. PubMed ID: 34741768
[TBL] [Abstract][Full Text] [Related]
33. Permeability Characteristics of a New Antifungal Topical Amphotericin B Formulation with γ-Cyclodextrins.
López-Castillo C; Rodríguez-Fernández C; Córdoba M; Torrado JJ
Molecules; 2018 Dec; 23(12):. PubMed ID: 30567325
[TBL] [Abstract][Full Text] [Related]
34. Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.
Al-Ghabeish M; Xu X; Krishnaiah YS; Rahman Z; Yang Y; Khan MA
Int J Pharm; 2015 Nov; 495(2):783-91. PubMed ID: 26343911
[TBL] [Abstract][Full Text] [Related]
35. Characterisation and in vitro stability of low-dose, lidocaine-loaded poly(vinyl alcohol)-tetrahydroxyborate hydrogels.
Abdelkader DH; Osman MA; El-Gizawy SA; Faheem AM; McCarron PA
Int J Pharm; 2016 Mar; 500(1-2):326-35. PubMed ID: 26802495
[TBL] [Abstract][Full Text] [Related]
36. Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels.
Ricci EJ; Bentley MV; Farah M; Bretas RE; Marchetti JM
Eur J Pharm Sci; 2002 Nov; 17(3):161-7. PubMed ID: 12393144
[TBL] [Abstract][Full Text] [Related]
37. Development and Comparison of Nanosponge and Niosome based Gel for the Topical Delivery of Tazarotene.
Aggarwal G; Nagpal M; Kaur G
Pharm Nanotechnol; 2016; 4(3):213-228. PubMed ID: 29052500
[TBL] [Abstract][Full Text] [Related]
38. Sugar ester J-1216 enhances percutaneous permeation of ionized lidocaine.
Okamoto H; Sakai T; Tokuyama C; Danjo K
J Pharm Sci; 2011 Oct; 100(10):4482-90. PubMed ID: 21626509
[TBL] [Abstract][Full Text] [Related]
39. The effect of rheological behavior and microstructure of the emulgels on the release and permeation profiles of Terpinen-4-ol.
Dong L; Liu C; Cun D; Fang L
Eur J Pharm Sci; 2015 Oct; 78():140-50. PubMed ID: 26144369
[TBL] [Abstract][Full Text] [Related]
40. Influence of Concentration on Release and Permeation Process of Model Peptide Substance-Corticotropin-From Semisolid Formulations.
Siemiradzka W; Dolińska B; Ryszka F
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
